MEI Pharma (MEIP) Competitors $2.35 +0.01 (+0.43%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$2.34 -0.01 (-0.43%) As of 03/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEIP vs. VHAQ, MGX, QNCX, GANX, TNYA, ACHL, VOR, BYSI, STTK, and OCXShould you be buying MEI Pharma stock or one of its competitors? The main competitors of MEI Pharma include Viveon Health Acquisition (VHAQ), Metagenomi (MGX), Quince Therapeutics (QNCX), Gain Therapeutics (GANX), Tenaya Therapeutics (TNYA), Achilles Therapeutics (ACHL), Vor Biopharma (VOR), BeyondSpring (BYSI), Shattuck Labs (STTK), and OncoCyte (OCX). These companies are all part of the "pharmaceutical products" industry. MEI Pharma vs. Viveon Health Acquisition Metagenomi Quince Therapeutics Gain Therapeutics Tenaya Therapeutics Achilles Therapeutics Vor Biopharma BeyondSpring Shattuck Labs OncoCyte MEI Pharma (NASDAQ:MEIP) and Viveon Health Acquisition (NYSE:VHAQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, community ranking, dividends, earnings, profitability, valuation and institutional ownership. Is MEIP or VHAQ more profitable? Viveon Health Acquisition's return on equity of 0.00% beat MEI Pharma's return on equity.Company Net Margins Return on Equity Return on Assets MEI PharmaN/A -84.92% -67.53% Viveon Health Acquisition N/A N/A N/A Does the MarketBeat Community believe in MEIP or VHAQ? MEI Pharma received 416 more outperform votes than Viveon Health Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformMEI PharmaOutperform Votes41662.93% Underperform Votes24537.07% Viveon Health AcquisitionN/AN/A Which has better valuation & earnings, MEIP or VHAQ? MEI Pharma has higher revenue and earnings than Viveon Health Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMEI Pharma$65.30M0.24$17.78M-$5.73-0.41Viveon Health AcquisitionN/AN/A-$610KN/AN/A Do insiders and institutionals hold more shares of MEIP or VHAQ? 52.4% of MEI Pharma shares are held by institutional investors. Comparatively, 22.1% of Viveon Health Acquisition shares are held by institutional investors. 3.1% of MEI Pharma shares are held by company insiders. Comparatively, 75.3% of Viveon Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer MEIP or VHAQ? In the previous week, MEI Pharma had 3 more articles in the media than Viveon Health Acquisition. MarketBeat recorded 3 mentions for MEI Pharma and 0 mentions for Viveon Health Acquisition. MEI Pharma's average media sentiment score of 0.96 beat Viveon Health Acquisition's score of 0.00 indicating that MEI Pharma is being referred to more favorably in the media. Company Overall Sentiment MEI Pharma Positive Viveon Health Acquisition Neutral Which has more volatility & risk, MEIP or VHAQ? MEI Pharma has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Viveon Health Acquisition has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500. Do analysts rate MEIP or VHAQ? MEI Pharma presently has a consensus price target of $7.00, indicating a potential upside of 197.87%. Given MEI Pharma's stronger consensus rating and higher possible upside, equities research analysts plainly believe MEI Pharma is more favorable than Viveon Health Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MEI Pharma 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Viveon Health Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryMEI Pharma beats Viveon Health Acquisition on 9 of the 12 factors compared between the two stocks. Remove Ads Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEIP vs. The Competition Export to ExcelMetricMEI PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.66M$6.90B$5.63B$7.84BDividend YieldN/A2.77%5.33%4.01%P/E Ratio-0.417.2623.6018.74Price / Sales0.24218.62388.2390.77Price / Cash0.4465.6738.1734.64Price / Book0.716.386.894.23Net Income$17.78M$142.34M$3.20B$247.47M7 Day Performance2.17%-5.15%-3.06%-2.29%1 Month Performance-8.20%-7.55%1.52%-5.81%1 Year Performance-41.25%-11.06%9.37%-0.96% MEI Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEIPMEI Pharma4.3021 of 5 stars$2.35+0.4%$7.00+197.9%-41.3%$15.66M$65.30M-0.41100Short Interest ↓VHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumeMGXMetagenomi2.2261 of 5 stars$1.65+0.6%$14.40+772.7%-86.0%$61.68M$52.30M-0.63236Analyst RevisionNews CoverageQNCXQuince Therapeutics2.3262 of 5 stars$1.40+1.4%$9.60+585.7%+27.4%$61.60MN/A-1.1360Earnings ReportAnalyst ForecastShort Interest ↓News CoverageGANXGain Therapeutics3.0362 of 5 stars$2.32-0.9%$8.20+253.4%-49.9%$61.54M$50,000.00-2.1120Earnings ReportAnalyst ForecastNews CoveragePositive NewsTNYATenaya Therapeutics4.0867 of 5 stars$0.70+10.0%$6.25+792.9%-87.7%$61.31MN/A-0.49110Short Interest ↓Analyst RevisionNews CoverageACHLAchilles Therapeutics2.9193 of 5 stars$1.48flat$4.00+170.3%N/A$60.83MN/A-0.90250Upcoming EarningsNews CoverageVORVor Biopharma2.4104 of 5 stars$0.88+1.7%$8.86+901.5%-68.2%$60.74MN/A-0.54140BYSIBeyondSpringN/A$1.55-3.1%N/A-59.7%$60.50M$1.88M0.0080News CoverageGap DownSTTKShattuck Labs2.505 of 5 stars$1.24+3.3%$7.50+504.8%-88.2%$59.20M$6.44M-0.81100Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageOCXOncoCyte2.5514 of 5 stars$3.33-2.1%$4.42+32.6%+9.6%$58.12M$709,000.000.00120Earnings ReportAnalyst ForecastShort Interest ↑News Coverage Remove Ads Related Companies and Tools Related Companies Viveon Health Acquisition Alternatives Metagenomi Alternatives Quince Therapeutics Alternatives Gain Therapeutics Alternatives Tenaya Therapeutics Alternatives Achilles Therapeutics Alternatives Vor Biopharma Alternatives BeyondSpring Alternatives Shattuck Labs Alternatives OncoCyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEIP) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEI Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEIP Stock Free MEIP Stock Alerts